Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Olaussen KA et al. (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355: 983–991

    CAS  Article  Google Scholar 

  2. 2

    Potti A et al. (2006) A genomic strategy to refine prognosis in early stage non-small cell lung cancer. N Engl J Med 355: 570–580

    CAS  Article  Google Scholar 

  3. 3

    Chen HY et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11–20

    CAS  Article  Google Scholar 

  4. 4

    Bepler G et al. (2006) RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small cell lung cancer. J Clin Oncol 24: 4731–4737

    CAS  Article  Google Scholar 

  5. 5

    Rosell R et al. (2005) ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p) [abstract #7002]. J Clin Oncol 23 (Suppl 16S part I)

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Wei Zhou.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Heist, R., Liu, G. & Zhou, W. Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?. Nat Rev Clin Oncol 4, 564–565 (2007). https://doi.org/10.1038/ncponc0909

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing